The expression of EGFRL858R/T790M mutant protein is frequently found in lung cancer patients, we then investigated the effects of FBXL2 on the growth of EGFRL858R/T790M-driven NSCLC in vitro and in vivo. This evidence concerns the gene FBXL2 and non-small cell lung carcinoma.